Management of acute ST-segment elevation myocardial infarction. II. Beyond reperfusion.
The last issue of the Journal contains a continuing medical education article on reperfusion therapy in acute ST-segment elevation myocardial infarction (STEMI), and this article completes the sequence by discussing other aspects of the management of acute STEMI.
Glancy
D Luke
DL
Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, USA.
Subramaniam
Pramilla N
PN
Pappas
Nicholas D
ND
Lewis
Robert S
RS
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003326:Coronary Circulation; D019468:Disease Management; D004502:Education, Medical, Continuing; D004562:Electrocardiography; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008145:Louisiana; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D015425:Myocardial Reperfusion; D010351:Patient Discharge; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors